Bahrain authorizes use of Pfizer's anti-COVID drug -state news agency


Reuters | Cairo | Updated: 01-01-2022 21:14 IST | Created: 01-01-2022 21:14 IST
Bahrain authorizes use of Pfizer's anti-COVID drug -state news agency
  • Country:
  • Egypt

Bahrain's health authorities authorized Pfizer's Paxlovid COVID-19 drug for emergency use in adults aged over 18, the state news agency said in a statement on Saturday.

The decision by the National Authority for Regulating Health Professions and Services was based on the review and evaluation of data provided by Pfizer, the statement added.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback